SE448992B - Forfarande for framstellning av en omega-pentanorprostaglandin ur e- eller f-serierna - Google Patents
Forfarande for framstellning av en omega-pentanorprostaglandin ur e- eller f-seriernaInfo
- Publication number
- SE448992B SE448992B SE7314686A SE7314686A SE448992B SE 448992 B SE448992 B SE 448992B SE 7314686 A SE7314686 A SE 7314686A SE 7314686 A SE7314686 A SE 7314686A SE 448992 B SE448992 B SE 448992B
- Authority
- SE
- Sweden
- Prior art keywords
- omega
- preparing
- procedure
- series
- pentanor prostaglandin
- Prior art date
Links
- 150000003180 prostaglandins Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX502673U MX5600E (es) | 1972-11-08 | 1973-11-07 | Procedimiento para preparar intermediarios de omega-pentanorprostaglandinas sustituidas |
| MX502573U MX4888E (es) | 1972-11-08 | 1973-11-07 | Procedimiento para preparar 2-oxo-3fenoxipropil-fosfonato de dimetilo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30481372A | 1972-11-08 | 1972-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE448992B true SE448992B (sv) | 1987-03-30 |
Family
ID=23178133
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7314686A SE448992B (sv) | 1972-11-08 | 1973-10-29 | Forfarande for framstellning av en omega-pentanorprostaglandin ur e- eller f-serierna |
| SE7700718A SE431756B (sv) | 1972-11-08 | 1977-01-24 | Fenoxi-2-oxopropylfosfonat till anvendning som mellanprodukt vid framstellning av nya w-pentanorprostaglandiner |
| SE7700717A SE436278B (sv) | 1972-11-08 | 1977-01-24 | Cyklopentanderivat for anvendning sasom intermediat vid framstellning av prostaglandinforeningar |
| SE7700716A SE445111B (sv) | 1972-11-08 | 1977-01-24 | Substituerad omega-pentanorprostaglandin ur e- eller f-serien for anvendning som antifertilitetsmedel |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7700718A SE431756B (sv) | 1972-11-08 | 1977-01-24 | Fenoxi-2-oxopropylfosfonat till anvendning som mellanprodukt vid framstellning av nya w-pentanorprostaglandiner |
| SE7700717A SE436278B (sv) | 1972-11-08 | 1977-01-24 | Cyklopentanderivat for anvendning sasom intermediat vid framstellning av prostaglandinforeningar |
| SE7700716A SE445111B (sv) | 1972-11-08 | 1977-01-24 | Substituerad omega-pentanorprostaglandin ur e- eller f-serien for anvendning som antifertilitetsmedel |
Country Status (29)
| Country | Link |
|---|---|
| JP (3) | JPS5416491B2 (es) |
| AR (3) | AR200585A1 (es) |
| AT (3) | AT367034B (es) |
| AU (1) | AU470375B2 (es) |
| BE (1) | BE806995A (es) |
| CA (3) | CA1085831A (es) |
| CH (1) | CH597176A5 (es) |
| CS (3) | CS182793B2 (es) |
| DD (4) | DD118856A5 (es) |
| DE (1) | DE2355540C2 (es) |
| DK (1) | DK144247C (es) |
| ES (3) | ES420325A1 (es) |
| FI (1) | FI60389C (es) |
| FR (3) | FR2205335B1 (es) |
| GB (3) | GB1456514A (es) |
| HK (3) | HK27979A (es) |
| HU (3) | HU171819B (es) |
| IE (1) | IE39537B1 (es) |
| IL (1) | IL43589A (es) |
| IN (1) | IN139384B (es) |
| KE (3) | KE2932A (es) |
| MY (3) | MY7900243A (es) |
| NL (1) | NL164273C (es) |
| NO (3) | NO147836C (es) |
| PH (3) | PH13272A (es) |
| SE (4) | SE448992B (es) |
| SU (4) | SU584766A3 (es) |
| YU (3) | YU39715B (es) |
| ZA (1) | ZA738554B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3929862A (en) * | 1974-01-08 | 1975-12-30 | Upjohn Co | Substituted tolylesters of PGF{HD 2{B {60 |
| US3986764A (en) * | 1975-03-31 | 1976-10-19 | Gte Automatic Electric Laboratories Incorporated | Panel for supporting a pair of elongated mating connectors and selectively locking them together |
| GB1506816A (en) * | 1975-03-31 | 1978-04-12 | Upjohn Co | Prostaglandins |
| ES449162A1 (es) * | 1975-06-23 | 1977-12-16 | Syntex Inc | Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico. |
| GB1516414A (en) * | 1975-08-22 | 1978-07-05 | Ici Ltd | Prostane derivatives |
| SE7809008L (sv) * | 1977-12-12 | 1979-06-13 | Upjohn Co | Anvendning av amider av prostaglandintyp for att styra eller reglera reproduktionscykeln hos individer tillhorande deggdjursarter |
| DK523378A (da) * | 1978-01-16 | 1979-07-17 | Pfizer | Fremgangsmaade til fremstilling af n-(tetrazol-5-yl) prostaglandin-carboxamider eller salte deraf |
| WO1999012898A1 (en) * | 1997-09-09 | 1999-03-18 | The Procter & Gamble Company | Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| EP1159266B1 (en) | 1999-03-05 | 2004-11-03 | Duke University | C-16 unsaturated fp-selective prostaglandins analogs |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| JP2002329615A (ja) * | 2001-05-02 | 2002-11-15 | Ohira Denshi Kk | トロイダルコイル |
| US6476064B1 (en) * | 2001-06-13 | 2002-11-05 | Allergan, Inc. | Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents |
| WO2006047466A2 (en) | 2004-10-21 | 2006-05-04 | Duke University | Ophthamological drugs |
| US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1324737A (en) * | 1970-11-02 | 1973-07-25 | Upjohn Co | Prostaglandins and the preparation thereof |
| IE37602B1 (en) * | 1971-05-11 | 1977-08-31 | Ici Ltd | Cyclopentane derivatives |
-
1972
- 1972-11-07 DD DD182498*A patent/DD118856A5/xx unknown
-
1973
- 1973-10-29 SE SE7314686A patent/SE448992B/xx unknown
- 1973-11-07 CA CA185,274A patent/CA1085831A/en not_active Expired
- 1973-11-07 CH CH1563973A patent/CH597176A5/xx not_active IP Right Cessation
- 1973-11-07 DD DD182499*A patent/DD119411A5/xx unknown
- 1973-11-07 JP JP12527273A patent/JPS5416491B2/ja not_active Expired
- 1973-11-07 NL NL7315263.A patent/NL164273C/xx not_active IP Right Cessation
- 1973-11-07 GB GB2285876A patent/GB1456514A/en not_active Expired
- 1973-11-07 DD DD182497*A patent/DD117233A5/xx unknown
- 1973-11-07 DE DE2355540A patent/DE2355540C2/de not_active Expired
- 1973-11-07 BE BE1005485A patent/BE806995A/xx not_active IP Right Cessation
- 1973-11-07 AR AR250885A patent/AR200585A1/es active
- 1973-11-07 YU YU2880/73A patent/YU39715B/xx unknown
- 1973-11-07 AT AT0936973A patent/AT367034B/de not_active IP Right Cessation
- 1973-11-07 IL IL43589A patent/IL43589A/en unknown
- 1973-11-07 ZA ZA738554A patent/ZA738554B/xx unknown
- 1973-11-07 DD DD174504A patent/DD109212A5/xx unknown
- 1973-11-07 IN IN2448/CAL/73A patent/IN139384B/en unknown
- 1973-11-07 FI FI3443/73A patent/FI60389C/fi active
- 1973-11-07 GB GB5175873A patent/GB1456512A/en not_active Expired
- 1973-11-07 PH PH15191A patent/PH13272A/en unknown
- 1973-11-07 IE IE2002/73A patent/IE39537B1/xx unknown
- 1973-11-07 ES ES420325A patent/ES420325A1/es not_active Expired
- 1973-11-07 DK DK601073A patent/DK144247C/da not_active IP Right Cessation
- 1973-11-07 GB GB2395076A patent/GB1456513A/en not_active Expired
- 1973-11-07 AU AU62247/73A patent/AU470375B2/en not_active Expired
- 1973-11-07 NO NO4288/73A patent/NO147836C/no unknown
- 1973-11-07 FR FR7339544A patent/FR2205335B1/fr not_active Expired
- 1973-11-08 CS CS7500006065A patent/CS182793B2/cs unknown
- 1973-11-08 HU HU73PI00000452A patent/HU171819B/hu unknown
- 1973-11-08 CS CS7300007669A patent/CS182791B2/cs unknown
- 1973-11-08 HU HU72PI00000399A patent/HU172703B/hu unknown
- 1973-11-08 HU HU73PI451A patent/HU173507B/hu unknown
- 1973-11-08 CS CS7500006066A patent/CS182794B2/cs unknown
- 1973-11-11 SU SU7301971722A patent/SU584766A3/ru active
-
1974
- 1974-06-06 AR AR254090A patent/AR202931A1/es active
- 1974-06-06 AR AR254091A patent/AR199966A1/es active
- 1974-09-26 NO NO743493A patent/NO148998C/no unknown
- 1974-12-18 ES ES433047A patent/ES433047A1/es not_active Expired
- 1974-12-18 ES ES433046A patent/ES433046A1/es not_active Expired
-
1975
- 1975-02-18 NO NO750535A patent/NO149139C/no unknown
- 1975-02-18 SU SU752106791A patent/SU667141A3/ru active
- 1975-02-19 SU SU752106125A patent/SU893130A3/ru active
- 1975-07-24 PH PH17410A patent/PH13110A/en unknown
- 1975-07-24 PH PH17409A patent/PH13325A/en unknown
- 1975-08-22 FR FR7526059A patent/FR2279729A1/fr active Granted
- 1975-08-22 FR FR7526060A patent/FR2283146A1/fr active Granted
-
1976
- 1976-07-23 AT AT544676A patent/AT353285B/de active
- 1976-07-23 AT AT544576A patent/AT360672B/de not_active IP Right Cessation
- 1976-10-15 JP JP51123737A patent/JPS5253841A/ja active Pending
- 1976-10-15 JP JP51123738A patent/JPS5257147A/ja active Pending
-
1977
- 1977-01-24 SE SE7700718A patent/SE431756B/xx not_active IP Right Cessation
- 1977-01-24 SE SE7700717A patent/SE436278B/xx not_active IP Right Cessation
- 1977-01-24 SE SE7700716A patent/SE445111B/xx not_active IP Right Cessation
- 1977-07-11 CA CA341,897A patent/CA1088930A/en not_active Expired
- 1977-07-11 CA CA341,898A patent/CA1088931A/en not_active Expired
-
1978
- 1978-07-27 SU SU782629453A patent/SU745362A3/ru active
-
1979
- 1979-03-15 KE KE2932A patent/KE2932A/xx unknown
- 1979-03-15 KE KE2930A patent/KE2930A/xx unknown
- 1979-03-15 KE KE2931A patent/KE2931A/xx unknown
- 1979-05-03 HK HK279/79A patent/HK27979A/xx unknown
- 1979-05-03 HK HK281/79A patent/HK28179A/xx unknown
- 1979-05-03 HK HK280/79A patent/HK28079A/xx unknown
- 1979-12-30 MY MY243/79A patent/MY7900243A/xx unknown
- 1979-12-30 MY MY246/79A patent/MY7900246A/xx unknown
- 1979-12-30 MY MY245/79A patent/MY7900245A/xx unknown
-
1980
- 1980-10-23 YU YU2706/80A patent/YU37316B/xx unknown
- 1980-10-23 YU YU2707/80A patent/YU36975B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE404019B (sv) | Forfarande for framstellnig av n-fosfonometylglycin | |
| NO144223C (no) | Fremgangsmaate til fremstilling av strekkbart papir | |
| SE400771B (sv) | Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner | |
| SE448992B (sv) | Forfarande for framstellning av en omega-pentanorprostaglandin ur e- eller f-serierna | |
| SE413246B (sv) | Forfarande for framstellning av kolesteroloxidas | |
| NO140731C (no) | Fremgangsmaate for fremstilling av dimetyleter | |
| SE419339B (sv) | Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner | |
| NO139124C (no) | Fremgangsmaate for fremstilling av estere | |
| NL157290B (nl) | Werkwijze ter bereiding van antrachinon. | |
| SE382053B (sv) | Forfarande for framstellning av bifenylylalkanoylaminopyridiner | |
| SE392609B (sv) | Forfarande for framstellning av metanhaltiga gaser | |
| SE7505080L (sv) | Forfarande for framstellning av butyndiol. | |
| SE383151B (sv) | Forfarande for framstellning av 1-hydroxi-2-pyridoner | |
| FI55626C (fi) | Anordning foer framstaellning av en behaollare | |
| SE423092B (sv) | Forfarande for framstellning av vissa 13-tiaprostaglandiner | |
| SE7611202L (sv) | Forfarande for framstellning av pyrazolodiazepinforeningar | |
| NO139130C (no) | Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner | |
| NL7502326A (nl) | Werkwijze ter bereiding van herbiciden. | |
| SE400768B (sv) | Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon | |
| SE380272B (sv) | Forfarande for framstellning av n-fosfonmetylglycin | |
| SE385589B (sv) | Forfarande for framstellning av steroider ur prednisolonserien | |
| SE385581B (sv) | Forfarande for framstellning av foretrade n-metylolkarbamidforeningar | |
| NL7514641A (nl) | Werkwijze ter bereiding van herbiciden. | |
| FI56830B (fi) | Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider | |
| SE402454B (sv) | Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen |